Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Jolly Health Industry Investment Management is a specialized investment firm based in China that focuses on the healthcare and life sciences sectors. As a strategic investment arm associated with Zhejiang Jolly Pharmaceutical, the company identifies and funds high-growth opportunities in pharmaceuticals, medical technology, and healthcare services. The firm aims to integrate industrial resources with financial capital to support the modernization and expansion of the health industry in China. Its portfolio and management activities typically encompass traditional Chinese medicine, chemical drugs, and innovative medical service providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Jolly Health Industry Investment Management.